ICU Medical Inc.
Last updated September 27, 2026
Organization details
- Legal name
- ICU Medical Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Clemente
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ICUI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000883984
- EIN
- 33-0022692
Board of directors
-
David C. Greenberg · DirectorSince 2023
-
David F. Hoffmeister · DirectorSince 2023
-
Donald Abbey · DirectorSince 2023
-
Elisha W. Finney · DirectorSince 2023
-
George A. Lopez · DirectorSince 2024
-
Kolleen T. Kennedy · DirectorSince 2023
-
Laurie Hernandez · DirectorSince 2023
-
Vivek Jain · Director · Chairman and CEOSince 2023
Chief executives
Vivek Jain
· Chairman and CEO
Dates unknown
Director election results
Annual meeting of May 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.6%
-
98.6%
-
98.8%
-
98.8%
-
98.8%
-
98.8%
-
99.1%
Board connections
4 of this board's directors also sit on 7 other boards.
- via David F. Hoffmeister
- via Vivek Jain
- via David F. Hoffmeister
- via Kolleen T. Kennedy
- via Elisha W. Finney
- via David F. Hoffmeister
- via Elisha W. Finney
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $8,266,247
- 19 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 3, 2026 | Sanzone Virginia Ruth Officer (VP, General Counsel) | Open-market sale | −2,202 | $167.67 | $369,203 |
| Sep 3, 2026 | Sanzone Virginia Ruth Officer (VP, General Counsel) | Open-market sale | −1,238 | $168.44 | $208,523 |
| Sep 3, 2026 | Sanzone Virginia Ruth Officer (VP, General Counsel) | Open-market sale | −724 | $169.53 | $122,736 |
| Sep 3, 2026 | Sanzone Virginia Ruth Officer (VP, General Counsel) | Open-market sale | −692 | $171.52 | $118,688 |
| Sep 1, 2026 | Bonnell Brian Michael Officer (Chief Financial Officer) | Open-market sale | −6,381 | $175.00 | $1,116,675 |
| Aug 31, 2026 | Bonnell Brian Michael Officer (Chief Financial Officer) | Open-market sale | −1,712 | $171.05 | $292,843 |
| Aug 31, 2026 | Bonnell Brian Michael Officer (Chief Financial Officer) | Open-market sale | −1,914 | $172.12 | $329,443 |
| Aug 31, 2026 | Bonnell Brian Michael Officer (Chief Financial Officer) | Open-market sale | −4,568 | $173.44 | $792,291 |
| Aug 31, 2026 | Bonnell Brian Michael Officer (Chief Financial Officer) | Open-market sale | −1,113 | $173.91 | $193,567 |
| Aug 13, 2026 | Woolson Daniel Officer (VP, GM-Infusion Capital) | Open-market sale | −5,417 | $181.33 | $982,265 |
| Aug 12, 2026 | Sousa Ben Officer (Chief Information Officer) | Open-market sale | −2,250 | $178.32 | $401,209 |
| Aug 11, 2026 | Elisha W. Finney Director | Open-market sale | −378 | $182.48 | $68,978 |
| Aug 11, 2026 | Voigtlander Christian B. Officer (Chief Operating Officer) | Open-market sale | −8,929 | $182.93 | $1,633,404 |
| May 22, 2026 | Woolson Daniel Officer (President) | Open-market sale | −2,123 | $132.21 | $280,682 |
| May 14, 2026 | Sanzone Virginia Ruth Officer (VP, General Counsel) | Open-market sale | −2,447 | $124.08 | $303,624 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.